| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.39% | +2.87% | +54.81% | +112.29% | 1,038B | |
| -0.48% | +0.42% | +54.03% | +67.18% | 649B | |
| +0.42% | +1.18% | +19.57% | +74.25% | 467B | |
| -0.19% | +0.97% | +34.30% | +45.99% | 355B | |
| +0.28% | +2.30% | +18.47% | +26.67% | 269B | |
| +0.89% | +4.59% | +10.19% | +14.72% | 260B | |
| +3.64% | +8.41% | +42.40% | +52.13% | 213B | |
| -0.46% | -6.20% | -32.46% | -59.65% | 176B | |
| +1.39% | +4.50% | +35.91% | +103.81% | 187B | |
| Average | +0.60% | +1.04% | +26.36% | +48.60% | 401.68B | |
| Weighted average by Cap. | +0.42% | +1.47% | +36.22% | +67.00% |
Employees
4
Sector
Pharmaceuticals
